How to treat small cell lung cancer effectively

How to effectively treat small cell lung cancer? Cancer has taken away many lives in our lives, so we all feel that cancer is terrible. Small cell lung cancer is highly malignant and has a short doubling time. So today we will take a look at how to effectively treat small cell lung cancer.

It is very terrifying to see how rapidly small cell lung cancer develops in the late stage, and its spread throughout the body is very obvious. However, despite this, late-stage small cell lung cancer is quite sensitive to systemic chemotherapy, and the five-year survival rate of patients with late-stage small cell lung cancer can reach about 10% through systemic chemotherapy.

Although advanced small cell lung cancer can be treated with chemotherapy, it is still necessary to pay attention to the cycle control of chemotherapy. Generally speaking, it is best to control the chemotherapy cycle within six weeks. It should not be treated with high-dose chemotherapy. This high-dose chemotherapy is highly aggressive to the patient's own tissues and is not conducive to improving the patient's quality of life.

If small cell lung cancer reaches the late stage, various symptoms are more prominent, and the patient's quality of life begins to decline rapidly. In order to reduce the symptoms that affect the patient's quality of life, radiotherapy can be used. During radiotherapy, about 70% of the symptoms of advanced lung cancer can be controlled, thereby reducing the patient's pain to a minimum.

Note: Radiotherapy is a double-edged sword. Although it can relieve symptoms for lung cancer, its toxic side effects on the body cannot be underestimated. Therefore, high-dose treatment plans should not be used during radiotherapy, and the main focus should be on relieving symptoms.

Commonly used treatments for small cell lung cancer include: surgery, chemotherapy, radiotherapy, targeted therapy, immunotherapy, and traditional Chinese medicine treatment. However, the best treatment effect of small cell lung cancer depends on the degree of progression of the patient's disease.